✨ Free AI Report
Verily Life Sciences: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Verily Life Sciences
Company Research

Verily Life Sciences: Business Overview, Financials & Competitive Analysis

Verily Life Sciences scores 7/10 on the AskCyborg Cyborg Score (Solid). A well-capitalized healthcare AI and data platform company with proven partnerships and hardware assets, positioned to scale chronic disease management and clinical evidence generation under independent leadership as of March 2026.

What is Verily Life Sciences's industry? Verily Life Sciences (verily.com) operates in Digital Health. AskCyborg classifies Verily Life Sciences under Digital Health in its company registry.

Verily Life Sciences is a developer and manufacturer of healthcare tools and devices designed to predict and prevent disease onset and progression. The company offers products including glucose monitors, smart lenses,...

7/ 10Solid

Cyborg Score thesis

A well-capitalized healthcare AI and data platform company with proven partnerships and hardware assets, positioned to scale...

Read the full analyst-debate transcript →
Industry Digital Health
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 26, 2026
AI-Generated Research
30+ Page Report

Get the Latest Verily Life Sciences Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Verily Life Sciences

AskCyborg analysts argue the bull and bear cases for Verily Life Sciences across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Verily Life Sciences OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Verily Life Sciences Overview

Pro stress-test →

Verily Life Sciences is a developer and manufacturer of healthcare tools and devices designed to predict and prevent disease onset and progression. The company offers products including glucose monitors, smart lenses, bioelectronic medicines, surgical robots and precision medicines, enabling consumers to collect health data in timely decision-making and effective interventions.

Strategic Profile

Pro stress-test →

In March 2026, the company underwent a significant corporate restructuring, changing its legal name to Verily Health, Inc. and transitioning from an LLC to a corporation following a $300 million investment round, with Alphabet becoming a significant minority investor and relinquishing its controlling stake. The company's primary technology infrastructure, the "Pre" platform, serves as an end-to-end ecosystem that harmonizes fragmented health data; clinical evidence generation solutions facilitate decentralized clinical trials; and care delivery includes virtual care solutions and personalized management programs for chronic conditions through its Onduo brand.

Competitive Landscape

Pro stress-test →

Verily's top competitors include iRhythm Technologies, Ginkgo Bioworks, Johnson & Johnson Innovation, and Helix. Verily differentiates through its integrated platform combining hardware (wearables, glucose monitors), software (Pre platform, Project Baseline), and care delivery (Onduo), positioning it against narrower point-solution competitors.

Industry Context

Verily Life Sciences operates in Digital Health.

Key facts

Founded: 2015 · Headquarters: South San Francisco, US · Employees: 1,400 · Revenue: Estimated $300M–$500M (based on strategic partnerships and funding activity as of mid-2026)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Verily Life Sciences.

  • In March 2026, Verily underwent a corporate restructuring with a $300 million investment round that transformed the company from a majority Alphabet-controlled subsidiary to an independent corporation, signaling strong institutional validation for its platform and products.
  • Verily's products include the Verily Study Watch and continuous glucose monitoring devices developed in partnership with Dexcom, which serve healthcare providers and researchers to enhance clinical research and patient outcomes.
+1 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Corporate restructuring: Legal name change to Verily Health, Inc.; $300M investment round; Alphabet transitions from controlling to minority investor
  • October 2025Launched consumer health app Verily Me at HLTH USA conference
  • +1 moreTrack every material event for Verily Life Sciences as it happens. Explore monitoring →
Get alerted when Verily Life Sciences has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Wearable Cardiac MonitoringDigital health and wearable monitoring platforms→Synthetic Biology & Biotech PlatformAI-driven synthetic biology and precision health solutions→Healthcare Innovation & Digital HealthHealthcare diagnostics, devices, and digital care solutions→Digital Health & Clinical ResearchAI-powered health data and genomics platform→

Compare Verily Life Sciences with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Verily Life Sciences operates in Digital Health. See how the rest of the sector scores on the Cyborg framework.

Browse Digital Health research →
NEW · MCP server

Ask your AI assistant about Verily Life Sciences

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Verily Life Sciences and its top competitor on Cyborg Score”
“What did Verily Life Sciences do this quarter?”
“Is Verily Life Sciences a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Verily Life Sciences do?+
Verily Life Sciences is a developer and manufacturer of healthcare tools and devices designed to predict and prevent disease onset and progression. The company offers products including glucose monitors, smart lenses,...
What is Verily Life Sciences's Cyborg Score?+
Verily Life Sciences has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Verily Life Sciences's main competitors?+
Named competitors include Wearable Cardiac Monitoring, Synthetic Biology & Biotech Platform, Healthcare Innovation & Digital Health, Digital Health & Clinical Research. The full competitive landscape is in the AskCyborg report.
How can I get the full Verily Life Sciences research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Verily Life Sciences research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Verily Life Sciences over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Digital Health research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Hinge Health, Inc.7Owlet, Inc.4American Well Corporation4DocMorris AG3Hims & Hers Health, Inc.